Document Detail

Blood pressure-lowering treatment for primary and secondary prevention of different types of stroke.
MedLine Citation:
PMID:  19505278     Owner:  NLM     Status:  MEDLINE    
High blood pressure is the most important modifiable risk factor for stroke and accumulating evidence indicates that blood pressure levels are likely to be associated with all stroke subtypes. There is also evidence from randomized trials suggesting that blood pressure-lowering treatment provides protection against every stroke subtype in both primary and secondary prevention settings. Blood pressure lowering is likely to be one of the most effective and generalizable strategies across a variety of stroke subtypes.
Hisatomi Arima
Related Documents :
7709398 - Weather and stroke in a subtropical area: ilan, taiwan.
2129448 - A haemodynamic study of hypotension during haemodialysis using electrical bioimpedance ...
20532438 - Reduced blood pressure variability in ascot-bpla trial favours use of amlodipine/perind...
3883848 - Protamine: a review of its toxicity.
24275338 - Successful treatment of negative pressure hydrocephalus using timely titrated external ...
14763898 - Can lymphatic drainage be measured non-invasively in human limbs, using plethysmography?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  7     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-09     Completed Date:  2009-08-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  627-36     Citation Subset:  IM    
George Institute for International Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, PO Box M201, Missenden Road, NSW 2050, Sydney, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / therapeutic use
Blood Pressure / drug effects*
Hypertension / complications,  drug therapy*,  physiopathology
Primary Prevention / methods
Randomized Controlled Trials as Topic
Risk Factors
Secondary Prevention / methods
Stroke / etiology,  physiopathology,  prevention & control*
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hypertension in obstructive sleep apnea: risk and therapy.
Next Document:  Management of hypertension in acute stroke.